Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

When do you expect the FDA to approve monoclonal antibody therapy for CLL patients?

Ask the Doctor Question:

When do you except the FDA to approve monoclonal antibody therapy for CLL patients?

Answer: We are monitoring the situation closely and have been in contact with FDA officials behind the scenes to push them to make this a priority. We have received responses back that they are aware of the needs of the immunocompromised and they “will be working on it.” So unfortunately, no timeline yet. We have been told from AZ that it could take anywhere from 6 weeks to 6 months. But it is honestly anyone’s guess.

Keep an eye on the website, as we will be letting our community know as soon as we hear any updates.